EpigenCare logo
Website

EpigenCare

ICO

EpigenCare is a biotech company for personalized skincare by combining epigenetics and blockchain technology. EpigenCare creates a personalized skincare platform that combines epigenetic testing with ingredient-based algorithms to screen for brands that are best suited to the current quality of users’ skin.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Product typeTechnology
WhitepaperEpigenCare White Paper Open

What is EpigenCare

EpigenCare web platform empowers users with the knowledge of which products truly work for their skin. Instead of generalized marketing, companies will use EpigenCare matching system to market their brands to users based on their unique skin profile - if it's not qualified for their skin on a functionally biological level, it gets rejected. Matching is filtered by EpigenCare A.I. algorithm based on epigenetic, toxicity, and absorbance effects of the ingredients on the tested skin quality indicators. All EPIC token holders will receive 15% & 10% revenue distribution (payable as ETH) in the first two years of operation, respectively. Afterwards, EPIC holders will receive 5% quarterly of all revenue, including skincare test sales and product match sales.

Details

Pre-sales: Mar 19, 2018 - Apr 15, 2018
Public sales: Apr 16, 2018 - Jul 31, 2018
Token supply: 60,000,000
Hard cap: 20,000,000 USD(fiat)

Token info

Ticker: EPIC
Type: Utility-token
Token distribution:
83.3% - Crowdsale Supply
10%  -Founders
6.2% - Key Employees
0.5% - Advisory Team
Funds allocation:
50% - Product Development & Operations
35% - Marketing & Business Development:
10% - Administration
5% - Legal

EpigenCare Roadmap

1
Q2, 2017

EpigenCare Inc. Established in New York, USA

2
Q4 2017

Epigenetic-based Skincare Test Successfully Developed and Proven

3
Q1 2018

ICO Token Generation Event

4
Q2 2018

Launch Marketing Campaign for Product Pre-Orders

5
Q3 2018

Limited Launch of Beta Skincare Test

6
Q4 2018

Full Skincare Test Launch to Public; Launch EpigenCare Network Open Beta

7
Q1 2019

Launch Consumer Mobile Application

8
Q2 2019

Launch Official EpigenCare Network Platform

9
Q3 2019

Retail Distribution Initiative; Deploy API (Application Programming Interface)

10
Q4 2019

Dermatologist/Spa/Beauty Salon Partnership Initiative

11
Future Objectives

Integrate Deep-Learning Artificial Intelligence Elements Based on Epigenetic Skin Data; Develop Complementary A-I-Based Mobile Imaging Application

Project team

William Lee
William Lee
Chief Executive Officer
William Lee linkedin
Adam Weiwei Li, Md, Ph.d.
Adam Weiwei Li, Md, Ph.d.
Chief Scientific Officer
Adam Weiwei Li, Md, Ph.d. linkedin
Jessica Li
Jessica Li
Chief Financial Officer
Jessica Li linkedin
Ashley Pottash
Ashley Pottash
Business Strategy Lead
Ashley Pottash linkedin
Stephen Fiser
Stephen Fiser
Software Development Lead
Stephen Fiser linkedin

Advisors

Richard Wildnauer, Ph.D.
Richard Wildnauer, Ph.D.
Business Advisor
Richard Wildnauer, Ph.D. linkedin
James Wang, MD
James Wang, MD
Dermatology Advisor
James Wang, MD linkedin
Brennan Bennett
Brennan Bennett
Blockchain Advisor
Brennan Bennett linkedin
Rebecca Fry, Ph.D.
Rebecca Fry, Ph.D.
Epigenetics Advisor
Rebecca Fry, Ph.D. linkedin
Tim Bukher
Tim Bukher
Legal Strategy Advisor

Social media

EpigenCare web-siteEpigenCare RedditEpigenCare MediumEpigenCareYouTubeEpigenCare TelegramEpigenCare BTCTalkEpigenCare LinkedInEpigenCare X (Twitter)EpigenCare FacebookEpigenCare Github

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects

Newly Published